Skip to main content

Xortx Therapeutics Inc(XRTX-X)
TSX Venture

Today's Change
Delayed Last Update

Xortx Therapeutics Inc

3710 - 33rd Street NW
Calgary AB T2L 2M1 CAN
P: 403-455-7727
F: 403-260-3501
https://www.xortx.com

Sectors & Indices

Sector
Industry
Employees

Profile

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

Key Executives

NameTitle
Allen Warren DavidoffCEO/Director/President
Michael BumbyCFO
Stephen HaworthChief Medical Officer
Stacy EvansOther Executive Officer

More from The Globe